Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for NEC Prophylaxis in Premature Infants
NCT06333405Recruiting
- Sponsor
- Medical University of Warsaw
- Start
- Feb 2026
- Primary completion
- Oct 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Open-label trial of allogeneic fecal microbiota in necrotizing enterocolitis (NEC) (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Adverse reactions monitoring. Started Feb 2026; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT06333405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06333405.